Credit Agricole’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-150,000
Closed -$3.82M 1298
2025
Q3
$3.82M Buy
+150,000
New +$3.7M 0.01% 618
2025
Q1
$3.8M Sell
150,000
-200,000
-57% -$5.23M 0.01% 592
2024
Q4
$9.29M Hold
350,000
0.03% 408
2024
Q3
$10.1M Buy
350,000
+269,018
+332% +$7.85M 0.04% 281
2024
Q2
$2.27M Sell
80,982
-169,018
-68% -$4.65M 0.01% 536
2024
Q1
$6.35M Sell
250,000
-1,275,000
-84% -$35.4M 0.07% 227
2023
Q4
$43.9M Buy
1,525,000
+1,450,000
+1,933% +$43.8M 0.5% 41
2023
Q3
$2.49M Buy
75,000
+66,562
+789% +$2.35M 0.04% 259
2023
Q2
$310K Buy
+8,438
New +$328K 0.01% 393
2023
Q1
Sell
-47,334
Closed -$2.43M 733
2022
Q4
$2.43M Buy
+47,334
New +$2.27M 0.05% 222
2020
Q4
Sell
-16,864
Closed -$587K 612
2020
Q3
$587K Buy
+16,864
New +$591K 0.03% 218

Other funds holding PFE

Credit Agricole's PFE Position: Q1 2026 in Review

Credit Agricole reduced its Pfizer (PFE) stake by 62% in Q1 2026, selling an estimated $51.1M and leaving 1,186,021 shares worth $33.3M. The position accounts for 0.09% of the portfolio, ranked #178.

Credit Agricole first reported a position in PFE in Q3 2013 and has held it in 50 quarters since. The position peaked at $434M in Q3 2017. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Credit Agricole held 1,186,021 shares of Pfizer worth $33.3M as of Q1 2026.
  • Credit Agricole sold 1,920,775 Pfizer shares in Q1 2026, an estimated $51.1M.
  • Pfizer made up 0.09% of Credit Agricole's portfolio in Q1 2026, its #178 holding.
  • Credit Agricole first reported a position in Pfizer in Q3 2013 and has held it in 50 quarters since.
  • Credit Agricole's Pfizer position peaked at $434M in Q3 2017.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Credit Agricole's 13F filing for Q1 2026, filed 15 May 2026.